Product Information
LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1561 per EA under NDC 00378728753. Its NADAC has been published 621 times since Aug 6, 2014.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378728753
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200245On Market Since
6/26/2014
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 621 times since Aug 6, 2014, and over the history we have for it it has declined 65.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1561 per EA |
|---|---|
| All-time high | $0.5937 (Apr 13, 2016) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1518 |
| Median price | $0.2475 |
| Average price | $0.2955 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 621 |
| Tracking since | Aug 6, 2014 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.1561 per EA (NDC 00378728753), effective Jun 24, 2026.
How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has declined 65.2%. It has been tracked across 621 weekly CMS publications since Aug 6, 2014.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Since Aug 6, 2014, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.5937 (Apr 13, 2016), with a median of $0.2475 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1125 per EA — about 28% below LEVONOR-ETH ESTRAD 0.1-0.02 MG.
Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?
LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 00378728753) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification